Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the Quarter Ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has submitted a routine compliance certificate under SEBI's Depository Regulations for the quarter ended March 31, 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (Purva Sharegistry India Pvt. Ltd.), confirms that all share certificates received for dematerialization during the quarter were properly verified, accepted or rejected, and the physical certificates were mutilated and cancelled within prescribed timelines. The filing also includes a detailed list of share certificates converted from physical to demat form by various shareholders between January and March 2025, with most lots being 50 shares each. The largest individual conversion came from Khem-Sum Apparels Overseas Ltd, which dematerialized 11 lots totaling 550 shares. This is a standard quarterly regulatory submission with no business or financial information disclosed.
This is a routine procedural filing with no impact on the company's operations, financials, or stock price. Shareholders and investors should note no material information — only confirmation that dematerialization requests were processed normally during the quarter.